Finance

Lists
Why is ANGO down 4,39%?
Dive Deeper
ANGO:NASDAQ
AngioDynamics, Inc.
10,90 US$
-4,39%
(-0,50) 1D
10,90 US$
0,00% (0,00)
After hours
Closed: 13 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ANGO...
Open
11,43 US$
High
11,52 US$
Low
10,62 US$
Mkt. cap
458,39 მლნ.
Avg. vol.
711,43 ათ.
Volume
1,35 მლნ.
52-wk high
16,29 US$
52-wk low
9,39 US$
EPS
-0,88 US$
Beta
0,30
Shares outstanding
42,05 მლნ.
No. of employees
632
Open
11,43 US$
High
11,52 US$
Low
10,62 US$
Mkt. cap
458,39 მლნ.
Avg. vol.
711,43 ათ.
Volume
1,35 მლნ.
52-wk high
16,29 US$
52-wk low
9,39 US$
EPS
-0,88 US$
Beta
0,30
Shares outstanding
42,05 მლნ.
No. of employees
632
News stories
From web sources and news partners
About AngioDynamics, Inc.
CEOჯეიმს კლემერ
Employees632
Founded9 თებ. 1988
Headquarters-
SectorMedical device
Analyst ratings
Based on 3 analysts giving stock ratings to ANGO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ANGO in the last 3 months.
Highest
Current 10,90 US$
24,00 US$ (+120,18%)
Average
20,67 US$ (+89,63%)
Lowest
18,00 US$ (+65,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Yi Chen
H.C. Wainwright
Buy
Maintained
18,00 US$
+65,1%
10/13/2026
John Young CFA
Canaccord Genuity
Buy
Reiterated
20,00 US$
+83,5%
10/09/2026
Frank Takkinen
Lake Street
Buy
Maintained
24,00 US$
+120,2%
07/14/2026
Ilya Zubkov
Freedom Capital Markets
Buy
Initiated
16,00 US$
+46,8%
04/06/2026
Last report
8 ოქტ. 2026
Fiscal period
Q1 2027
-0,04 US$ / -0,11 US$
+64,70%beat
Revenue / Est. (USD)
80,92 მლნ. / 80,50 მლნ.
+0,52%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ნოე. 2025
თებ. 2026
მაი. 2026
აგვ. 2026
Revenue
79,43 მლნ.
78,42 მლნ.
86,61 მლნ.
80,92 მლნ.
Cost of goods sold
34,65 მლნ.
36,94 მლნ.
39,83 მლნ.
34,08 მლნ.
Cost of revenue
34,65 მლნ.
36,94 მლნ.
39,83 მლნ.
34,08 მლნ.
Research and development expenses
7,63 მლნ.
6,93 მლნ.
8,03 მლნ.
7,82 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
37,00 მლნ.
38,31 მლნ.
41,53 მლნ.
42,61 მლნ.
Operating expense
47,27 მლნ.
47,91 მლნ.
52,42 მლნ.
53,16 მლნ.
Total operating expenses
81,92 მლნ.
84,85 მლნ.
92,26 მლნ.
87,24 მლნ.
Operating income
-2,49 მლნ.
-6,43 მლნ.
-5,65 მლნ.
-6,32 მლნ.
Other non operating income
-128,00 ათ.
4,97 მლნ.
-735,00 ათ.
94,00 ათ.
EBT including unusual items
-6,36 მლნ.
-8,07 მლნ.
-11,04 მლნ.
-7,30 მლნ.
EBT excluding unusual items
-2,72 მლნ.
-1,55 მლნ.
-6,49 მლნ.
-6,32 მლნ.
Income tax expense
-5,00 ათ.
12,00 ათ.
370,00 ათ.
-199,00 ათ.
Effective tax rate
0,08%
-0,15%
-3,35%
2,73%
Other operating expenses
-
-
138,00 ათ.
-
Net income
-6,35 მლნ.
-8,08 მლნ.
-11,40 მლნ.
-7,10 მლნ.
Net profit margin
-7,99%
-10,31%
-13,17%
-8,77%
Earnings per share
-
0,02
-0,07
-0,04
Interest and investment income
-
12,00 ათ.
1,00 ათ.
-
Interest expense
-102,00 ათ.
-100,00 ათ.
-106,00 ათ.
-88,00 ათ.
Net interest expenses
-102,00 ათ.
-88,00 ათ.
-105,00 ათ.
-88,00 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
3,26 მლნ.
-838,00 ათ.
-353,00 ათ.
-823,00 ათ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები